Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / CD Molecules

Recombinant Mouse CD55 Protein, N-His

Catalog #:   YMC30901 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q61475
Protein length: Asn44-Lys289
Overview

Catalog No.

YMC30901

Expression system

E. coli

Species

Mus musculus (Mouse)

Protein length

Asn44-Lys289

Predicted molecular weight

29.57 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q61475

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Complement decay-accelerating factor, CR, DAF, CD55

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Mouse CD55 protein
References

Human CD55 Expression and C1 Inhibition Partially Protect Gene-Edited Pig Red Blood Cells From Human Complement-Mediated Hemolysis In Vitro., PMID:40492338

Therapeutic targets for Alzheimer's disease: Proteome-wide Mendelian randomization and colocalization analyses., PMID:40452368

Natural killer cells adopt an activated and decidual-like phenotype after autologous hematopoietic stem cell transplantation in children with cancer., PMID:40437214

The decay-accelerating factor (CD55) in acute leukemia patients and its query implication in cancer pathogenesis., PMID:40419851

Evidence for Complement Activation in Preeclampsia Placenta and Its Presence in Circulation., PMID:40388260

CD55 upregulation in T cells of COVID-19 patients suppresses type-I interferon responses., PMID:40316776

Complement dysregulation at lymphatics., PMID:40300720

Mechanism and regulation of the complement activity in kidney xenotransplantation., PMID:40233672

Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages., PMID:40148202

Bioinformatic analysis of serpina1 expression in papillary thyroid carcinoma and its potential association with Hashimoto's thyroiditis., PMID:40106166

Stromal Cell Subsets Show Model-Dependent Changes in Experimental Colitis and Affect Epithelial Tissue Repair and Immune Cell Activation., PMID:40100003

Claudin-2 enhances human antibody-mediated complement-dependent cytotoxicity of porcine endothelial cells by modulating antibody binding and complement activation., PMID:40040710

Complement activity and autophagy are dysregulated in the lungs of patients with nonresolvable COVID-19 requiring lung transplantation., PMID:40016722

Evaluation of Complement-Dependent Cytotoxicity Assays for Gene-Edited Pig-to-Human Xenotransplantation., PMID:39960350

Gene expression regulation and polyadenylation in ulcerative colitis via long-chain RNA sequencing., PMID:39955510

SARS-CoV-2 enhances complement-mediated endothelial injury via the suppression of membrane complement regulatory proteins., PMID:39945674

Establishment of a Panel of Human Cell Lines to Identify Cellular Receptors Used by Enteroviruses to Infect Cells., PMID:39940693

Neutrophil-derived vesicles control complement activation to facilitate inflammation resolution., PMID:39938514

The patient experience of CHAPLE disease: results from interviews conducted as part of a clinical trial for an ultra-rare condition., PMID:39934837

Discovery of a second, distinct development pattern of leukemic conversion from paroxysmal nocturnal hemoglobinuria., PMID:39910008

Mitochondrial injury and complement dysregulation are drivers of pathological inflammation in viral myocarditis., PMID:39846741

Complement regulators as novel targets for anti-cancer therapy: A comprehensive review., PMID:39826189

Evaluation of Complement-Dependent Cytotoxicity Assays for Gene-Edited Pig-to-Human Xenotransplantation., PMID:39825616

Exosome-Mediated Lectin Pathway and Resistin-MIF-AA Metabolism Axis Drive Immune Dysfunction in Immune Thrombocytopenia., PMID:39792656

SNRNP70 regulates the splicing of CD55 to promote osteosarcoma progression., PMID:39704173

EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma., PMID:39695702

A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer., PMID:39693144

An evaluation of pozelimab for the treatment of CHAPLE disease., PMID:39657032

CD55 characterizes regulatory T cells with reduced functionality and is downregulated in rheumatoid arthritis., PMID:39657534

Deciphering proteins in Alzheimer's disease: A new Mendelian randomization method integrated with AlphaFold3 for 3D structure prediction., PMID:39637861

Generation and characterization of genetically modified pigs with GGTA1/β4GalNT2/CMAH knockout and human CD55/CD47 expression for xenotransfusion studies., PMID:39622959

Essential role of Moringa-albumin (MA) formulation in the maintenance of complement regulatory proteins on erythrocyte (TER-119) cells in diabetic mouse models., PMID:39526711

Clinical Significance of Complement and Coagulation Cascades Genes for Patients With Acute Lymphoblastic Leukemia., PMID:39523585

SARS-CoV-2 hijacks host CD55, CD59 and factor H to impair antibody-dependent complement-mediated lysis., PMID:39435487

RBC subpopulations in RCCs affected by donor factors., PMID:39426025

CD151 identifies an NK cell subset that is enriched in COVID-19 patients and correlates with disease severity., PMID:39374860

N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts., PMID:39360848

Complement biosensors identify a classical pathway stimulus in complement-mediated thrombotic microangiopathy., PMID:39357054

[The rs2564978(T) Allele Associated with Severe Influenza A Disrupts the Binding Site for Myeloid Differentiation Factor PU.1 and Reduces CD55/DAF Gene Promoter Activity in Macrophages]., PMID:39355884

Population pharmacokinetic analyses of pozelimab in patients with CD55-deficient protein-losing enteropathy (CHAPLE disease)., PMID:39349796

Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson's disease., PMID:39342308

A Histological Analysis and Detection of Complement Regulatory Protein CD55 in SARS-CoV-2 Infected Lungs., PMID:39337843

Complement-Mediated Two-Step NETosis: Serum-Induced Complement Activation and Calcium Influx Generate NADPH Oxidase-Dependent NETs in Serum-Free Conditions., PMID:39273570

Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors., PMID:39273426

Single-cell RNA sequencing identifies inherent abnormalities of adipose-derived stem cells from nonlesional sites of patients with localized scleroderma., PMID:39215271

Erythropoietin Effect on Complement Activation in Chronic Kidney Disease., PMID:39200211

Iscalimab Combined With Transient Tesidolumab Prolongs Survival in Pig-to-Rhesus Monkey Renal Xenografts., PMID:39185772

NETWORK ANALYSIS OF SINGLE-NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH ABERRANT INFLAMMATION IN TRAUMA PATIENTS SUGGESTS A ROLE FOR VESICLE-ASSOCIATED INFLAMMATORY PROGRAMS INVOLVING CD55., PMID:39178207

Senescence-related genes and proteins in the development of Alzheimer's disease: evidence from transcriptomic and Mendelian randomization analysis., PMID:39156738

Pozelimab for CHAPLE disease: results from in-trial interviews and clinical outcome assessments., PMID:39118150

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Mouse CD55 Protein, N-His [YMC30901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only